St. Jude Medical Announces FDA Approval of Smaller ICD

St. Jude Medical, Inc.

, a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of its Ellipse™ implantable cardioverter defibrillator (ICD). Designed with feedback from more than 200 physicians from around the world, the Ellipse ICD offers physicians unique design advancements, resulting in the industry's smallest high-energy ICD.